Lucid Diagnostics Inc. (NASDAQ: LUCD) Stock Information | RedChip

Lucid Diagnostics Inc. (NASDAQ: LUCD) Listen to this Section


$0.82
-0.0145 ( -1.74% ) 69.6K

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Market Data


Open


$0.82

Previous close


$0.84

Volume


69.6K

Market cap


$41.20M

Day range


$0.82 - $0.89

52 week range


$0.63 - $1.72

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
10-k Annual reports 100 Mar 25, 2024
8-k 8K-related 18 Mar 14, 2024
4 Insider transactions 2 Feb 23, 2024
4 Insider transactions 2 Feb 23, 2024
4 Insider transactions 2 Feb 23, 2024
4 Insider transactions 1 Feb 23, 2024
4 Insider transactions 2 Feb 23, 2024
4 Insider transactions 1 Feb 20, 2024
8-k 8K-related 14 Jan 30, 2024
4 Insider transactions 1 Jan 30, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.